患者特异性及基因编辑诱导多能干细胞衍生心肌细胞揭示Brugada综合征单细胞表型
本研究利用2例携带不同SCN5A变异的1型Brugada综合征患者及2名健康对照的皮肤成纤维细胞,通过无整合Sendai病毒重编程为iPSC并定向分化为心肌细胞。BrS iPSC-CMs显示钠电流密度降低、动作电位最大上升速度减慢,且触发活动、钙瞬变异常和搏动间期变异增加;基因编辑纠正致病变异后上述异常缓解。
要点
- BrS iPSC-CMs重现了钠电流密度降低和动作电位最大上升速度减慢。
- BrS iPSC-CMs触发活动负担增加、钙瞬变异常及搏动间期变异增大。
- 基因编辑纠正致病变异后触发活动和钙瞬变异常缓解。
核心结论
- 患者特异性iPSC-CMs能够重现Brugada综合征的单细胞表型特征,包括内向钠电流减弱、触发活动增加和钙处理异常。
研究设计与样本
- 研究纳入2例携带2种不同SCN5A变异的1型Brugada综合征患者和2名健康对照者。
- 用无整合Sendai病毒从皮肤成纤维细胞重编程为iPSC,并经定向分化获得纯化的iPSC-CMs。
主要发现
- 与健康对照iPSC-CMs相比,BrS iPSC-CMs的内向钠电流密度降低,动作电位最大上升速度减慢。
- BrS iPSC-CMs的触发活动负担增加,钙瞬变异常,搏动间期变异增大。
- 基因编辑纠正致病变异后,iPSC-CMs的触发活动和异常钙瞬变缓解。
- iPSC-CMs基因表达谱显示BrS与对照聚类分离,且BrS iPSC-CM基因表达与BrS人类心脏组织基因表达相关。
临床怎么用
- 该人源细胞模型可用于进一步阐明Brugada综合征的细胞疾病机制并识别新的治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Brugada syndrome (BrS), a disorder associated with characteristic electrocardiogram precordial ST-segment elevation, predisposes afflicted patients to ventricular fibrillation and sudden cardiac death. Despite marked achievements in outlining the organ level pathophysiology of the disorder, the understanding of human cellular phenotype has lagged due to a lack of adequate human cellular models of the disorder. OBJECTIVES: The objective of this study was to examine single cell mechanism of Brugada syndrome using induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). METHODS: This study recruited 2 patients with type 1 BrS carrying 2 different sodium voltage-gated channel alpha subunit 5 variants as well as 2 healthy control subjects. We generated iPSCs from their skin fibroblasts by using integration-free Sendai virus. We used directed differentiation to create purified populations of iPSC-CMs. RESULTS: BrS iPSC-CMs showed reductions in inward sodium current density and reduced maximal upstroke velocity of action potential compared with healthy control iPSC-CMs. Furthermore, BrS iPSC-CMs demonstrated increased burden of triggered activity, abnormal calcium (Ca2+) transients, and beating interval variation. Correction of the causative variant by genome editing was performed, and resultant iPSC-CMs showed resolution of triggered activity and abnormal Ca2+ transients. Gene expression profiling of iPSC-CMs showed clustering of BrS compared with control subjects. Furthermore, BrS iPSC-CM gene expression correlated with gene expression from BrS human cardiac tissue gene expression. CONCLUSIONS: Patient-specific iPSC-CMs were able to recapitulate single-cell phenotype features of BrS, including blunted inward sodium current, increased triggered activity, and abnormal Ca2+ handling. This novel human cellular model creates future opportunities to further elucidate the cellular disease mechanism and identify novel therapeutic targets.
引用
- Liang P, Sallam K, Wu H, et al. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome. J Am Coll Cardiol. 2016. PMID: 27810048. doi:10.1016/j.jacc.2016.07.779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。